Pismet Tablet 15/850 mg
Metformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
AhnGuk NewPharm Co., Ltd.
MFDS item code 201903552 · Approved 2019.05.29
This product's status changed to Expired on 2024.05.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improves blood glucose control in type 2 diabetes mellitus
This medication is used to help control blood sugar in patients with insulin-independent diabetes, i.e., type 2 diabetes. It is particularly administered when sufficient blood sugar control is difficult with monotherapy using metformin or pioglitazone or as an alternative to combined therapy with pioglitazone and metformin. For managing type 2 diabetes, it is very important to also adhere to dietary and exercise regimens, as these lifestyle improvements greatly enhance the effectiveness of medication therapy. Therefore, this medication is intended to improve blood sugar control and contribute to diabetes management when used alongside appropriate lifestyle habits.
For the treatment of patients with type 2 diabetes, the dose of this medicine should be individualized based on efficacy and tolerability, without exceeding the maximum dose of each component: pioglitazone 30mg and metformin 2500mg. The initial dose of this medicine should be based on the patient's current treatment regimen. 1. Patients whose blood glucose is not adequately controlled with metformin or pioglitazone monotherapy: The dose should be based on the current dose of metformin or pioglitazone. Start with 1 tablet of this medicine once daily and gradually adjust the dose after assessing the adequacy of the treatment response. 2. Patients switching from combination therapy with pioglitazone and metformin: Patients switching from combination therapy with pioglitazone and metformin to this medicine may start at their existing doses of pioglitazone and metformin. No studies have been conducted to assess the safety and efficacy of switching from other oral antihyperglycemic agents to this medicine. Any change in treatment for type 2 diabetes may alter glycemic control; therefore, caution should be exercised and appropriate monitoring performed. 3. Patients with renal impairment: All dose adjustments should be based on a careful assessment of renal function. In general, elderly, debilitated, and malnourished patients should not be titrated to the maximum dose of this medicine. After administering this medicine to a patient or increasing the dose, carefully monitor for adverse reactions associated with fluid retention. This medicine should generally be administered in divided doses with meals to reduce gastrointestinal adverse reactions caused by metformin. Allow sufficient time to assess the adequacy of the treatment response. Ideally, the response to treatment should be assessed using glycated hemoglobin (HbA1C), which is a better indicator of long-term glycemic control than fasting plasma glucose (FPG). HbA1c reflects blood glucose levels over the past 2 - 3 months. In clinical use of this medicine, if glycemic control measured by FPG has not worsened, administration for an adequate period (8-12 weeks) to assess the change in HbA1C is recommended.
This medication helps to control blood sugar. However, caution should be exercised when taking this medication due to the risk of a rare side effect known as lactic acidosis. Lactic acidosis is a dangerous condition that occurs when excessive lactic acid builds up in the body, which can be life-threatening in severe cases. Patients with impaired kidney function, heart disease, or liver dysfunction may have a higher risk of lactic acidosis, so it is essential to consult a doctor before using this medication. Additionally, this medication may worsen heart failure, so it is advisable for patients with severe heart disease not to use it. Excessive alcohol consumption may interact with this medication and increase the risk of lactic acidosis, so it is best to avoid drinking alcohol. Regular monitoring of kidney and liver functions is advisable during the period of taking this medication, and if any unusual symptoms (e.g., fatigue, muscle pain, difficulty breathing, abdominal pain, etc.) appear, immediate medical consultation is necessary. Furthermore, this medication may cause hypoglycemia, so caution is required when skipping meals or engaging in sudden vigorous exercise. Pregnant or breastfeeding women, patients with severe heart failure, and those with significantly impaired liver or kidney function should not take this medication. Regular blood glucose monitoring and checking vitamin B12 levels during treatment with this medication is recommended. Finally, this medication should be used with caution in patients with a history of bladder cancer, and if symptoms such as urinary disturbances or hematuria occur, the physician should be notified immediately.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a closed container to protect it from air and moisture. It is advisable to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature.
White to grayish white film-coated tablet
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Metformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
AhnGuk NewPharm Co., Ltd.
Pioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Celltrion Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Genewon Science Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Dalim Biotech Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Metformin Hydrochloride · Pioglitazone Hydrochloride
Prescription medication · Combination
Nexpam Korea Co., Ltd.
CombinationPioglitazone Hydrochloride 16.53mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Korea Prime Pharmaceutical Co., Ltd.
CombinationMetformin Hydrochloride 850mg · Pioglitazone Hydrochloride 16.53mg
Tablet · Prescription medication · Combination
Ilhwa Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.